Home-Wuhan Createrna Science and Technology Co.,Ltd.

  • m6官方旗舰店 m6官方旗舰店 banner1.jpg banner1ph1-907.jpg
    Provide patients with advanced treatment options
  • m6官方旗舰店 m6官方旗舰店 weibiaoti1.jpg weibiaoti3.jpg
    You and I rejoice in health
  • m6官方旗舰店 m6官方旗舰店 banner3.jpg banner3ph.jpg
    Provide professional products for human health
  • 1.Provide patients with advanced treatment options

  • 2.You and I rejoice in health

  • 3.Provide professional products for human health

m6官方旗舰店

Slide

m6官方旗舰店

Company Introduction

About Us

Wuhan Createrna Science and Technology Co.,Ltd. is an innovative drug research and development company. Adhering to the dual-driven strategy of simultaneous improvement of R&D pipeline and platform construction, Createrna has built a new drug R&D system covering the whole process from POC, candidate compound screening, preclinical druggability development to clinical research.

  • 240+

    Employee

    m6官方旗舰店 aicon04.svg
  • 180+

    Researchers

    m6官方旗舰店 aicon05.svg
  • 15+

    Projects

    m6官方旗舰店 aicon06.svg
  • 25+

    Pipelines

    m6官方旗舰店 aicon07.svg
  • 300+

    Partners

    m6官方旗舰店 aicon08.svg
m6官方旗舰店
m6官方旗舰店 m6官方旗舰店

Science

Research Ability

The whole process of research and development from candidate compound screening, preclinical druggability development to clinical research.

Pipeline

Createrna has built a rich pipeline of drug research and development varieties

Currently, Createrna has several projects under research in essential hypertension, chronic heart failure, anticoagulation and other indications, and has entered the clinical research stage.

Createrna is researching in IgA nephropathy, FSGS, diabetic nephropathy and other indications.

Createrna has a number of projects in chronic cough and idiopathic pulmonary fibrosis, and has already entered the clinical and IND phase.

Createrna has several drugs for the treatment of rheumatoid arthritis, psoriasis, inflammatory bowel disease, etc., and several projects have entered the clinical research stage.

abg0121.svg

Preclinical/IND

I Clinical Phase

II Clinical Phase

III Clinical Phase

Product Launch

Group13213186901.svg

Preclinical/IND

I Clinical Phase

II Clinical Phase

III Clinical Phase

Product Launch

Group1321318691.svg

Preclinical/IND

I Clinical Phase

II Clinical Phase

III Clinical Phase

Product Launch

Group13213186921.svg

Preclinical/IND

I Clinical Phase

II Clinical Phase

III Clinical Phase

Product Launch

m6官方旗舰店

Contact Us

Contact Us